Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review.
Eur J Pharm Sci. 2019 Jun 15;134:153-175. doi: 10.1016/j.ejps.2019.04.013. Epub 2019 Apr 13.
Eur J Pharm Sci. 2019.
PMID: 30991092
Free article.
Review.
Disposition of two highly permeable drugs in the upper gastrointestinal lumen of healthy adults after a standard high-calorie, high-fat meal.
Pentafragka C, Vertzoni M, Symillides M, Goumas K, Reppas C.
Pentafragka C, et al.
Eur J Pharm Sci. 2020 Apr 18;149:105351. doi: 10.1016/j.ejps.2020.105351. Online ahead of print.
Eur J Pharm Sci. 2020.
PMID: 32311455
Item in Clipboard
The impact of food intake on the luminal environment and performance of oral drug products with a view to in vitro and in silico simulations: a PEARRL review.
Pentafragka C, Symillides M, McAllister M, Dressman J, Vertzoni M, Reppas C.
Pentafragka C, et al.
J Pharm Pharmacol. 2019 Apr;71(4):557-580. doi: 10.1111/jphp.12999. Epub 2018 Sep 11.
J Pharm Pharmacol. 2019.
PMID: 30203429
Review.
Item in Clipboard
Characteristics of contents in the upper gastrointestinal lumen after a standard high-calorie high-fat meal and implications for the in vitro drug product performance testing conditions.
Pentafragka C, Vertzoni M, Dressman J, Symillides M, Goumas K, Reppas C.
Pentafragka C, et al.
Eur J Pharm Sci. 2020 Dec 1;155:105535. doi: 10.1016/j.ejps.2020.105535. Epub 2020 Aug 30.
Eur J Pharm Sci. 2020.
PMID: 32877722
Item in Clipboard
In Vitro Simulation of the Environment in the Upper Gastrointestinal Lumen After Drug Administration in the Fed State Using the TIM-1 System and Comparison With Luminal Data in Adults.
Pentafragka C, Tomaszewska I, Bellmann S, Minekus M, Schilderink R, Vertzoni M, McAllister M, Reppas C.
Pentafragka C, et al.
J Pharm Sci. 2022 Jan;111(1):197-205. doi: 10.1016/j.xphs.2021.10.010. Epub 2021 Oct 19.
J Pharm Sci. 2022.
PMID: 34673096
Item in Clipboard
Oral biopharmaceutics tools: recent progress from partnership through the Pharmaceutical Education and Research with Regulatory Links collaboration.
O'Dwyer PJ, Box KJ, Dressman J, Griffin BT, Henze LJ, Litou C, Pentafragka C, Statelova M, Vertzoni M, Reppas C.
O'Dwyer PJ, et al. Among authors: pentafragka c.
J Pharm Pharmacol. 2021 Mar 8;73(4):437-446. doi: 10.1093/jpp/rgaa055.
J Pharm Pharmacol. 2021.
PMID: 33793836
Review.
Item in Clipboard
Comparison of tumor size assessments in tumor growth inhibition-overall survival models with second-line colorectal cancer data from the VELOUR study.
Claret L, Pentafragka C, Karovic S, Zhao B, Schwartz LH, Maitland ML, Bruno R.
Claret L, et al. Among authors: pentafragka c.
Cancer Chemother Pharmacol. 2018 Jul;82(1):49-54. doi: 10.1007/s00280-018-3587-7. Epub 2018 Apr 26.
Cancer Chemother Pharmacol. 2018.
PMID: 29700575
Clinical Trial.
Item in Clipboard
Cite
Cite